Quince Therapeutics Inc. (QNCX)
NASDAQ: QNCX
· Real-Time Price · USD
1.70
0.02 (1.19%)
At close: Aug 15, 2025, 3:59 PM
1.62
-4.71%
After-hours: Aug 15, 2025, 07:43 PM EDT
Quince Therapeutics Income Statement
Financials in USD. Fiscal
year is
January - December.
Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 168K | 168K | 168K | 36K | 36K | 36K | 36K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | 202K | 246K | 254K | 474K | 388K | 345K | 322K | 60K | 100K | 183K | 204K | 246K | 293K | 296K | 344K | 260K | 173K | 86K |
Gross Profit | -34K | -78K | -86K | -438K | -352K | -309K | -286K | -60K | -100K | -183K | -204K | -246K | -293K | -296K | -344K | -260K | -173K | -86K |
Operating Income | -43.16M | -60.92M | -57.28M | -53.62M | -53.85M | -31.24M | -32.98M | -30.95M | -32.48M | -43.15M | -52.06M | -69.28M | -83.34M | -88.87M | -90.32M | -87.63M | -87.86M | -84.35M |
Interest Income | 1.94M | 2.45M | 2.93M | 3.41M | 3.68M | 3.67M | 3.48M | 3M | 2.36M | 1.7M | 1.07M | 637K | 450K | 465K | 620K | 812K | 1.09M | 1.59M |
Pretax Income | -48.9M | -60.61M | -56.74M | -53.13M | -53.01M | -30.2M | -31.58M | -28.27M | -30.84M | -42.8M | -51.94M | -69.81M | -83.59M | -88.5M | -89.94M | -87.1M | -86.9M | -82.76M |
Net Income | -49.03M | -60.71M | -56.83M | -53.26M | -53.12M | -30.28M | -31.39M | -28.31M | -31.18M | -42.86M | -52.02M | -69.6M | -83.09M | -88.28M | -89.94M | -87.1M | -86.9M | -82.76M |
Selling & General & Admin | 16.05M | 17.4M | 15.24M | 15.56M | 16.59M | 16.13M | 17.32M | 16.27M | 15.95M | 20.78M | 26.06M | 30.84M | 34.13M | 32.14M | 29.52M | 26.19M | 23.48M | 20.6M |
Research & Development | 25.44M | 23.03M | 18.39M | 16M | 12.51M | 9.72M | 9.45M | 8.78M | 9.8M | 15.65M | 25.18M | 37.62M | 49.21M | 56.73M | 60.79M | 61.44M | 64.38M | 63.75M |
Other Expenses | 1.68M | 20.49M | 18.57M | 18.55M | 21.23M | 1.88M | 1.88M | n/a | n/a | n/a | 150K | 190K | 33K | -98K | -248K | -288K | -131K | n/a |
Operating Expenses | 43.16M | 60.92M | 52.2M | 50.11M | 50.34M | 27.73M | 28.66M | 25.05M | 25.75M | 36.43M | 51.23M | 68.46M | 83.34M | 88.87M | 90.32M | 87.63M | 87.86M | 84.35M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | -2.34M | -2.64M | -2.64M | -2.64M | -304K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 32.73M | 60.92M | 57.28M | 55.19M | 55.42M | 32.82M | 28.66M | 25.05M | 25.75M | 36.43M | 51.23M | 68.46M | 83.34M | 88.87M | 90.32M | 87.63M | 87.86M | 84.35M |
Income Tax Expense | -94K | 9K | 87K | 131K | 118K | 82K | -197K | 36K | 337K | 53K | 79K | -205K | -477K | -222K | -227K | -227K | -256K | -227K |
Shares Outstanding (Basic) | 46.69M | 43.94M | 43.26M | 43.16M | 43.1M | 43.01M | 40.97M | 36.07M | 35.92M | 35.86M | 36.14M | 35.61M | 32.47M | 30.13M | 29.77M | 29.77M | 29.59M | 29.55M |
Shares Outstanding (Diluted) | 46.69M | 43.94M | 43.26M | 43.16M | 43.1M | 43.01M | 40.97M | 36.07M | 35.92M | 35.86M | 36.14M | 35.61M | 32.47M | 30.13M | 29.77M | 29.77M | 29.59M | 29.55M |
EPS (Basic) | -1.09 | -1.39 | -1.31 | -1.25 | -1.27 | -0.77 | -0.85 | -0.79 | -0.87 | -1.24 | -1.61 | -2.24 | -2.74 | -2.97 | -3.04 | -2.95 | -2.95 | -2.81 |
EPS (Diluted) | -1.09 | -1.39 | -1.31 | -1.25 | -1.27 | -0.77 | -0.85 | -0.79 | -0.87 | -1.24 | -1.61 | -2.24 | -2.74 | -2.97 | -3.04 | -2.95 | -2.95 | -2.81 |
EBITDA | -43.84M | -42.21M | -35.98M | -38.44M | -36.07M | -32.85M | -31.26M | -24.99M | -25.65M | -36.24M | -51.03M | -68.21M | -83.05M | -88.57M | -89.97M | -86.98M | -87.22M | -83.72M |
EBIT | -31.59M | -40.43M | -36.17M | -38.91M | -36.46M | -33.2M | -31.58M | -25.05M | -25.75M | -36.43M | -51.23M | -68.46M | -83.34M | -88.87M | -90.32M | -85.58M | -85.82M | -82.3M |
Depreciation & Amortization | 134K | 178K | 186K | 474K | 388K | 345K | 322K | 60K | 100K | 183K | 204K | 246K | 293K | 296K | 344K | 345K | 342K | 335K |